AUS
NZ
UK
CA
USA
IND
Healt
EBR Systems Advances Towards FDA Approval for WiSE Technology
September 30, 2024 06:35 PM AEST| By Team Kalkine MediaHighlights,EBR Systems has received FDA acceptance of its PMA application for the WiSE device, moving to a substantive review.,The FDA expedited the review process, completing its confirmation in just 30 days.,EBR anticipates FDA approval in Q1 2025,...
Anteris Technologies Adjusts Timeline for Nasdaq Listing
September 30, 2024 04:10 PM AEST| By Team Kalkine MediaHighlights,Anteris extends Nasdaq listing schedule.,Scheme meetings rescheduled to October or November 2024.,Focus,remains,on re-domiciliation and structural heart innovations.,Anteris Technologies Ltd,(ASX:AVR),has announced a revised timeline for i...
_08_02_2023_11_21_17_866226.jpg)
Polynovo (ASX:PNV): A Week of Gains Amid Market Fluctuations
September 30, 2024 02:45 PM AEST| By Team Kalkine MediaPolynovo Limited (ASX:PNV), Australia's fourth-largest pharmaceuticals and biotechnology company by market capitalization, has had a noteworthy week. The company's share price increased by 7.3% to close at AU$2.64. This rise stands in contrast to the...
Biome Australia Targets Significant Sales Growth Amid Industry Developments
September 30, 2024 12:51 PM AEST| By Team Kalkine MediaHighlights,Biome Australia aims to significantly increase sales over the next three years.,Anteris Technologies delays US IPO plans while progressing towards its goal.,Artrya,submits FDA application for its AI-based coronary disease detection product...
Mesoblast (ASX:MSB) Secures Funding Deal with Major Shareholder
September 30, 2024 12:47 PM AEST| By Team Kalkine MediaHighlights,Mesoblast secures AUD$72.7 million from top shareholder.,Funding will support marketing strategy for,Ryoncil,upon FDA approval.,Shares,rise,over 3% following the announcement.,Mesoblast (ASX:MSB), a developer of innovative therapies for in...
Pacific Smiles Rejects Genesis Bid Amid Competitive Offerings
September 30, 2024 10:50 AM AEST| By Team Kalkine MediaHighlights:,Pacific Smiles Group Ltd (,ASX:PSQ,) board,indicates,key shareholders intend to reject Genesis,Capital’s,$1.90 per share bid,,deeming,it below NDC,BidCo’s,offer of $2.05.,Genesis Capital holds a 19.9% interest in Pacific Smiles but has no...
ECS Botanics Holdings Shows Promising Gains Amid Ongoing Challenges
September 27, 2024 06:02 PM AEST| By Team Kalkine MediaHighlights,ECS Botanics Holdings Ltd has gained 38% in the last month.,The stock remains down 14% over the past year despite recent gains.,A low price-to-earnings ratio of 12.1x raises questions about future performance.,ECS Botanics Holdings Ltd (AS...
Healthcare Sector Sees Major Developments: Healius, Sigma, and Percheron Therapeutics in Focus
September 27, 2024 04:00 PM AEST| By Team Kalkine MediaHighlights,Healius sells Lumos Imaging to Affinity Equity Partners for $965m.,Sigma Healthcare awaits ACCC decision on Chemist Warehouse merger.,Percheron Therapeutics advances Phase 2B trial for Duchenne muscular dystrophy.,This week, the healthcare...
4DMedical Collaborates with Philips to Enhance Lung Imaging Technology
September 27, 2024 10:30 AM AEST| By Team Kalkine MediaHighlights,4DMedical signs reseller deal with Philips for US distribution.,Agreement aims to enhance lung imaging technology for veterans.,Partnership focuses on addressing respiratory diseases linked to military service.,4DMedical Ltd (ASX:4DX) has...
ASX Biotech Stocks Show Dynamic Developments
September 26, 2024 06:03 PM AEST| By Team Kalkine MediaHighlights,PYC Therapeutics highlights a significant valuation gap between late-stage and early-stage biotech companies.,OncoSil Medical reaches halfway in patient recruitment for pancreatic cancer trials, showcasing progress in its targeted radiatio...
Promising Trends in the Australian Healthcare Sector Post-FY24
September 26, 2024 11:08 AM AEST| By Team Kalkine MediaSummary Points,The Australian healthcare sector displays positive trends post-FY24 reporting, with rising revenue and margins among ASX-listed firms.,Companies like ResMed and CSL are gaining momentum, though challenges remain in pathology and aged c...
Southeast Asia Emerging as a Key Market for ASX Health Stocks
September 26, 2024 11:06 AM AEST| By Team Kalkine MediaSummary Points,Southeast Asia's aging population and growing middle class create significant opportunities for ASX health stocks.,Several Australian healthcare companies, including EZZ Life Science and Recce Pharmaceuticals, are expanding their prese...
Sigma Healthcare (ASX: SIG) Sees Earnings Drop from Chemist Warehouse Merger Costs
September 26, 2024 10:07 AM AEST| By Team Kalkine MediaHighlights,Sigma Healthcare reports a 67% drop in interim earnings due to merger costs with Chemist Warehouse.,Chemist Warehouse achieved strong growth with a net profit of $540 million for FY2024.,The ACCC's decision on the Sigma-Chemist Warehouse m...
Lumos Diagnostics Expands Reach in the U.S. with National Contract for FebriDx
September 25, 2024 06:05 PM AEST| By Team Kalkine MediaHighlights,Lumos Diagnostics secures a national contract with MediGroup for its FebriDx test in the U.S.,FebriDx delivers results in 10 minutes using a fingerstick blood sample, aiding quick diagnosis.,Lumos shares increased by 10.29% following the c...
Singular Health Surges 117% Year-to-Date as Key Investors Join
September 24, 2024 05:24 PM AEST| By Team Kalkine MediaIn a notable year for Singular Health (ASX:SHG), the medical imaging technology company has experienced a substantial rise of approximately 117% year-to-date. This growth has been bolstered by the support of significant investors, including Craig Sel...
Promising Innovations from Five ASX Biotech Pioneers
September 24, 2024 05:23 PM AEST| By Team Kalkine MediaMorgans senior analyst Scott Power initiated the Health Invest 2024 event, held in Sydney, with a comprehensive overview of the biotechnology and life sciences sectors to an audience that included both professional and retail investors. Power highlig...
Health Kick Podcast: PharmAust Tackles MND and ALS with Lead Drug Monepantel
September 24, 2024 05:22 PM AEST| By Team Kalkine MediaStockhead’s health and biotech expert, Tim Boreham, returns to the studio for another episode of the Health Kick Podcast. In this installment, Boreham engages in a conversation with Dr. Michael Thurn, the Managing Director at PharmAust (ASX:PAA).,Pha...
CSL (ASX:CSL) Faces Pressure, But Bell Potter Sees Buying Opportunity
September 24, 2024 01:48 PM AEST| By Team Kalkine MediaCSL Ltd (ASX:CSL) has experienced a challenging September, with its share price dropping more than 6% since the start of the month. In contrast, the ASX 200 index has recorded a modest gain of approximately 1% during the same timeframe. This decline...
Analyzing the Performance of CSL Ltd and Pro Medicus Limited in 2024
September 24, 2024 12:54 PM AEST| By Team Kalkine MediaAs of now, the share price of CSL Ltd has increased by 0.7% since the beginning of 2024, while Pro Medicus Limited is currently 1.2% shy of its 52-week high. This article explores the recent performance and fundamentals of both,ASX healthcare stocks,...
Actinogen Medical Accelerates Alzheimer’s Treatment Trials, Aiming for Fast-Track Global Approvals
September 24, 2024 12:42 PM AEST| By Team Kalkine MediaActinogen Medical (ASX:ACW) is making significant strides in the development of a novel oral treatment targeting Alzheimer’s disease and associated depression. The company is ramping up its clinical trials with fresh capital, positioning itself for a...
Advertise your brand on Kalkine Media